Sort   by:  
 Page size 
UnknownAdding Celecoxib With or Without Zoledronic Acid for Hormone-Naive Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.
Not available
S-EPMC5455701 | biostudies-literature
UnknownAbiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Not available
S-EPMC5533216 | biostudies-literature
UnknownAdding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Not available
S-EPMC5961425 | biostudies-literature
UnknownComparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data.
Not available
S-EPMC6637191 | biostudies-literature
UnknownDipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial.
Not available
S-EPMC9442496 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownBronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.
Not available
S-EPMC4114404 | biostudies-literature
UnknownAddition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Not available
S-EPMC4800035 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
UnknownHost-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Not available
S-EPMC3491803 | biostudies-literature
Sort   by:  
 Page size